Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.

× No keyword cloud information.

15 in total

Review 1. Meningococcal disease.

Authors: N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245

2. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.

Authors: A Arguedas; C Soley; C Loaiza; G Rincon; S Guevara; A Perez; W Porras; O Alvarado; L Aguilar; A Abdelnour; U Grunwald; L Bedell; A Anemona; P M Dull
Journal: Vaccine Date: 2010-02-26 Impact factor: 3.641

3. Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America.

Authors: D Stamboulian; G Lopardo; P Lopez; C Cortes-Barbosa; A Valencia; L Bedell; A Karsten; P M Dull
Journal: Int J Infect Dis Date: 2010-07-22 Impact factor: 3.623

4. Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaccine in adolescents and young adults.

Authors: Roberto Gasparini; Michele Conversano; Gianni Bona; Giovanni Gabutti; Alessandra Anemona; Peter M Dull; Francesca Ceddia
Journal: Clin Vaccine Immunol Date: 2010-02-17

5. Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2008-05-02 Impact factor: 17.586

Review 6. Optimizing protection against meningococcal disease.

Authors: Keith S Reisinger; Steven Black; Jeffrey J Stoddard
Journal: Clin Pediatr (Phila) Date: 2010-01-20 Impact factor: 1.168

Review 7. Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages.

Authors: Michael Bröker; Peter M Dull; Rino Rappuoli; Paolo Costantino
Journal: Vaccine Date: 2009-07-18 Impact factor: 3.641

8. Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra.

Authors: Keith S Reisinger; Roger Baxter; Stanley L Block; Jina Shah; Lisa Bedell; Peter M Dull
Journal: Clin Vaccine Immunol Date: 2009-10-07

9. A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents.

Authors: Lisa A Jackson; Robert M Jacobson; Keith S Reisinger; Alessandra Anemona; Lisa E Danzig; Peter M Dull
Journal: Pediatr Infect Dis J Date: 2009-02 Impact factor: 2.129

Review 10. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

Authors: David S Stephens; Brian Greenwood; Petter Brandtzaeg
Journal: Lancet Date: 2007-06-30 Impact factor: 79.321